0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1927 Views 
0 Saved
0 Vote 1 Contributor1927 Views 0 SavedYou might also be interested in
Only decades ago doctors and health professionals used to warn about the negative effects of having too much coffee because of the risk that caffeine was believed to have on your body. However, the last decade has shed so much light on the health benefits of coffee and its relationship with can....
Although some information came out over the past five years that wearing a bra can be linked with increased cancer risk, there is zero scientific evidence that this is true. Bras were created to help women’s chests feel more supported, no matter the activity, and to decrease any discomfort or back p....
You may find the hot flashes gradually decreasing with time after you start taking Arimidex; many women do. But we're talking years, not months, for them to vanish entirely. Some women even deal with hot flashes (usually much less intense and much less frequent) for the rest of their lives. Don't m....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.